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Abstract
The complement system is key to innate immunity and its activation is necessary for the clearance of bacteria and apoptotic
cells. However, insufficient or excessive complement activation will lead to immune-related diseases. It is so far unknown
how the complement activity is up- or down- regulated and what the associated pathophysiological mechanisms are. To
quantitatively understand the modulatory mechanisms of the complement system, we built a computational model
involving the enhancement and suppression mechanisms that regulate complement activity. Our model consists of a large
system of Ordinary Differential Equations (ODEs) accompanied by a dynamic Bayesian network as a probabilistic
approximation of the ODE dynamics. Applying Bayesian inference techniques, this approximation was used to perform
parameter estimation and sensitivity analysis. Our combined computational and experimental study showed that the
antimicrobial response is sensitive to changes in pH and calcium levels, which determines the strength of the crosstalk
between CRP and L-ficolin. Our study also revealed differential regulatory effects of C4BP. While C4BP delays but does not
decrease the classical complement activation, it attenuates but does not significantly delay the lectin pathway activation.
We also found that the major inhibitory role of C4BP is to facilitate the decay of C3 convertase. In summary, the present
work elucidates the regulatory mechanisms of the complement system and demonstrates how the bio-pathway machinery
maintains the balance between activation and inhibition. The insights we have gained could contribute to the development
of therapies targeting the complement system.
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Introduction
The complement system is pivotal to defending against invading
microorganisms. The complement proteins recognize conserved
pathogen-associated molecular patterns (PAMPs) on the surface of
the invading pathogens [1] to initiate the innate immunity
response. The complement activity also enhances adaptive
immunity [2,3] and participates in the clearance of apoptotic
cells [4] as well as damaged and altered self tissue. The
complement proteins in the blood normally circulate as inactive
zymogens. Upon stimulation, proteases in the system cleave the
zymogens to release active fragments and initiate an amplifying
cascade of further cleavages. There are three major complement
activation routes: the classical, the lectin and the alternative
pathways [5]. Regardless of how these pathways are initiated, the
complement activity leads to proteolytic activation and deposition
of the major complement proteins C4 and C3, which induces
phagocytosis, and the subsequent assembly of the membrane
attack complex which lyses the invading microbes. However,
complement is a double-edged sword; adequate complement
activation is necessary for killing the bacteria and removing the
apoptotic cells, while excessive complement activation can harm
the host by generating inflammation and exacerbating tissue
injury. Dysregulation of the balance between complement
activation and inhibition can lead to rheumatoid arthritis [6],
systemic lupus erythematosus [7], Alzheimer’s disease [8] and age-
related macular degeneration [9]. Since the final outcome of
complement related diseases may be attributable to the imbalance
between activation and inhibition [10], manipulation of this
balance using drugs represents an interesting therapeutic oppor-
tunity awaiting further investigation. In light of this potential,
complement inhibitors such as factor H and C4b-binding protein
(C4BP) are critical since they play important roles in tightly
controlling the proteolytic cascade of complement and avoiding
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activation and inhibition, as well as the roles of inhibitors, will
contribute towards the development of complement-based immu-
nomodulation therapies.
Complement is usually initiated by the interaction of several
pattern-recognition receptors with the surface of pathogens.
C-reactive protein (CRP) [11] and ficolins are two initiators of
the classical and lectin pathways, which boost immune responses
by recognizing phosphorylcholine (PC) or N-acetylglucosamine
(GlcNAc), respectively, displayed on the surface of invading
bacteria [12,13,14]. Recently, it was discovered that under local
infection-inflammation conditions as reflected by pH and calcium
levels, the conformations of CRP and L-ficolin change which leads
to a strong interaction between them [15]. This interaction triggers
crosstalk between classical and lectin pathways and induces new
amplification mechanisms, which in turn reinforces the overall
antibacterial activity and bacterial clearance.
On the other hand, C4BP, a major complement inhibitor is
synthesized and secreted by the liver. The estimated plasma
concentration of C4BP is 260 nM under normal physiological
condition [16] but its plasma level can be elevated up to four-fold
during inflammation [17,18]. Through its a-chain [19,20], C4BP
modulates complement pathways by controlling C4b-mediated
reactions in multiple ways [21,22,23]. Further, C4BP has been
proposed as a therapeutic agent for complement-related autoim-
mune diseases on the premise that mice models supplemented with
human C4BP showed attenuation in the progression of arthritis
[24]. Therefore, it is important to understand the systemic effect
and the underlying inhibitory mechanism of C4BP.
With this background, we constructed a detailed computational
model of the complement network consisting of a system of
ordinary Differential equations (ODEs). The large model size and
the many unknown kinetic rate parameters lead to significant
computational challenges. Using the technique developed in [25],
we approximated the ODE dynamics as a dynamic Bayesian
network [26] and used it to estimate the model parameters. After
constructing the model, we investigated the enhancement
mechanism induced by local inflammation and its interplay with
the inhibition mechanism induced by C4BP.
Our studies confirmed and further elucidated the previous
experimental findings [15]. Specifically, using our model we
established a detailed relationship between the antimicrobial
response and the strength of the crosstalk between CRP and L-
ficolin as determined by various combinations of the pH and
calcium levels. We also found that C4BP prevents complement
over-activation and restores homeostasis, but it achieves this in two
distinct ways depending on whether the complement activity was
initiated by PC or GlcNAc. Finally, the computational model
suggested that the major inhibitory effect of C4BP is to potentiate
the natural decay of C3 convertase (C4bC2a). These findings
regarding the role of C4BP were experimentally validated.
An earlier mathematical study [27] of the complement system
focused on the classical pathway. This study assumed the dynamics
to be linear, which is a severe restriction. A later study by
Korotaevskiy et al [28] more realistically assumed the dynamics to
be non-linear. It also included the alternative pathway. The main
focus was to derive quantitative conclusions regarding the lag time
of the immune response as the initial concentrations of the
constituent proteins were varied. Relative to [28], our model
additionally includes the lectin pathway and the recently identified
amplification pathways induced by the crosstalk between CRP and
L-ficolin [15]. On the other hand, given our focus on the up- and
down- regulation mechanisms of the complement, we do not
model the alternative pathway in detail since its role is to maintain
a basal level of complement activation. Instead, this basal activity
and the effects of other mechanisms such as C2 bypass [29] are
implicitly captured by the kinetic parameters in our model.
Results
We start with an overview of our results before getting into
details. The ODE model we constructed is based on the current
knowledge of the complement system. It includes the classical and
lectin pathways and the recently identified amplification pathways
[15]. Thus it is a moreaccurate reflection of the complement system
incomparisontotheearliermodels[27,28].Themodelconsistof42
species, 45 reactions and 85 kinetic parameters with 71 of the
parameters being unknown. To deal with the large number of
unknown kinetic parameters, we applied the technique developed
by Liu et al [25] and derived an approximation of the ODE model
as a Dynamic Bayesian Network (DBN) [26]. We then performed
parameter estimation using the DBN approximation and experi-
mentally generated test data. The resulting model was validated
using published observations of bacterial killing rates [15].
We next performed sensitivity analysis of the model, which
showed that the interaction between CRP and L-ficolin as well as
the decay of the C3 convertase played crucial roles. Since the
decay of C3 convertase is one of the regulatory targets of C4BP,
which had been identified as an important regulator [22,23,24],
we decided to investigate the role of C4BP under enhanced
complement activity as a part of our study.
Next we used the model to investigate the effects of pH and
calcium levels on the antibacterial response guided by previous
experimental findings [15]. We computed detailed response curves
of the antibacterial activity as a function of pH and calcium levels
which confirmed the findings in [15] and further elucidated the
enhancement of the cross talk between the classical and lectin
pathway under varying local inflammation conditions.
We then turned to the inhibitory role of C4BP. We found that for
PC-initiated complement activation, increasing the C4BP initial
Author Summary
The complement system, which is the frontline immune
defense, constitutes proteins that flow freely in the blood.
It quickly detects invading microbes and alerts the host by
sending signals into immune responsive cells to eliminate
the hostile substances. Inadequate or excessive comple-
ment activities harm the host and may lead to immune-
related diseases. Thus, it is crucial to understand how the
host boosts the complement activity to protect itself and
simultaneously establishes tight surveillance to attain
homeostasis. Towards this goal, we developed a detailed
computational model of the human complement system.
To overcome the challenges resulting from the large
model size, we applied probabilistic approximation and
inference techniques to train the model on experimental
data and explored the key network features of the model.
Our model-based study highlights the importance of
infection-mediated microenvironmental perturbations,
which alter the pH and calcium levels. It also reveals that
the inhibitor, C4BP induces differential inhibition on the
classical and lectin complement pathways and acts mainly
by facilitating the decay of the C3 convertase. These
predictions were validated empirically. Thus, our results
help to elucidate the regulatory mechanisms of the
complement system and potentially contribute to the
development of complement-based immunomodulation
therapies.
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amplitude of the response but it did not significantly alter the
magnitude of the peak response itself. On the other hand, for
GlcNAc-initiated complement activity, C4BP levels affected the
magnitudebutnotthe time takentoachievethispeak response.Our
subsequent experimental results agreed with these observations.
Finally, we investigated how C4BP mediates its inhibitory
function. According to current understanding, there are four
major mechanisms through which C4BP can inhibit complement
activation. Using the model, we determined that facilitating the
natural decay of C3 convertase is the most important inhibitory
function of C4BP. This finding was also validated experimentally.
Model construction
Given our focus on the amplification and down-regulation
mechanisms of complement, we included in our model only the
key proteins in the classical and lectin pathways. The basal activity
maintained by the alternative pathway and other mechanisms are
implicitly captured by the kinetic parameters in our model. A
schematic representation of the model structure is shown in
Figure 1A. The cascade of events captured by the model can be
described as follows.
The classical pathway is initiated by the binding of antibodies or
CRP to antigens or PAMPs. In our model, in order to decouple
the involvement of adaptive immune response, the classical
pathway is triggered by the binding of CRP to PC, which is a
ligand often displayed on the surface of the invading bacteria
[30,31]. Deposited CRP then binds to C1-complex (formed by
C1q, two molecules of C1r, and two molecules of C1s) that is
further activated. The activated C1-complex recruits C4 leading to
the cleavage of C4 to its fragments, C4b and C4a. After binding of
C2 to C4b, the same protease complexes are responsible for
generating fragments, C2a and C2b, by cleaving C2. The C2a and
C4b then form the C4bC2a complex, which is an active C3
convertase, cleaving C3 to C3a and C3b. The formation of C3b
exposes a previously hidden thioester group that covalently binds
to patches of hydroxyl and amino groups on the bacterial surface
[32]. The surface-deposited C3b plays a central role in all
subsequent steps of the complement cascade: (1) it acts as an
opsonin that enhances the binding and leads to the elimination of
bacteria by the phagocytes, (2) it induces the formation of
membrane attack complex leading to the lysis of bacteria. Since
the concentration of the deposited C3 reflects the antibacterial
activity of complement, we terminated our model at this step to
simplify the network.
On the other hand, the lectin pathway is initiated by the binding
of mannose-binding lectin (MBL) or ficolins to PAMPs on the
pathogen surface. In our model, we focused on the lectin pathway
initiated by L-ficolin as it can interact with CRP and induce
crosstalk between classical and lectin pathways. L-ficolin recog-
nizes various PAMPs on the bacterial surface via the acetyl group
on the GlcNAc moiety [33,34]. Therefore, in our model the lectin
pathway was triggered by binding of L-ficolin and GlcNAc onto
the bacterial surface. Subsequently, a protease zymogen called
MASP-2 is recruited and activated. Activated MASP-2 cleaves C4
and C2 to form C4bC2a which is C3 convertase. At this point, the
classical pathway and lectin pathway merge at the cleavage step of
the central complement protein, C3, and hence constitutes the
endpoint of our model.
As discovered in [15], infection-induced local inflammation
conditions (slight acidosis and hypocalcaemia) provoke a strong
crosstalk between CRP and L-ficolin [15]. This elicits two new
complement-amplification pathways, which reinforce the classical
and lectin pathways. Since we aimed to study the complement
activation and modulation under pathophysiological conditions,
we included these two amplification pathways (Figure 1A,
purple) in our model. Infection by bacteria containing PC will
induce the CRP:L-ficolin mediated amplification pathway:
PCRCRP:L-ficolinRMASP2RC4RC2RC3. On the other
hand, infection by bacteria containing GlcNAc will induce the
CRP:L-ficolin mediated amplification pathway: GlcNAcRCRP:
L-ficolinRC1RC4RC2RC3.
The complement allows a rapid attack to intruding bacteria
while at the same time protecting the host cells from over-
activation. C4BP, a major inhibitor of complement activation, was
reported to either accelerate the decay of the convertases or aid
proteolytic inactivation of key players in the pathway into inactive
forms such as factor H [32] but the systemic effect of C4BP has
remained unclear. Hence, in our model, we included this major
multifunctional inhibitor. Upstream of the complement cascade,
C4BP competes with C1 for the immobilized CRP [23].
Downstream to this, C4BP binds to C4b and serves as a cofactor
to the plasma serine protease factor I in the cleavage of C4b both
in the fluid phase and when C4b is deposited on bacterial surfaces
[21]. In addition, C4BP is able to prevent the assembly of the C3
convertase and accelerate the natural decay of the complex [35].
All of the above effects of C4BP are considered in our model and
the relevant components are depicted as red bars in Figure 1A.
The reaction network diagram of the model is shown in
Figure 1B. Processes such as protein association, degradation and
translocation are modeled with mass action kinetics and processes
such as cleavage, activation and inhibition with Michaelis-Menten
kinetics.
The resulting ODE model consists of 42 species, 45 reactions
and 85 kinetic parameters with 71 unknown. The details can be
found in the supporting information (Text S1).
Due to the large model size and many unknown kinetic
parameters, tasks such as parameter estimation and sensitivity
analyses became very challenging. Hence, we applied the
probabilistic approximation technique developed by Liu et al
[25] to derive a simpler model based on the standard probabilistic
graphical formalism called Dynamic Bayesian Networks (DBNs)
[26].
Briefly, this approximation scheme consists of the following
steps: (i) Discretize the value space of each variable and parameter
into a finite set of intervals. (ii) Discretize the time domain into a
finite number of discrete time points. (iii) Sample the initial states
of the system according to an assumed uniform distribution over
certain intervals of values of the variables and parameters. (iv)
Generate a trajectory for each sampled initial state and view the
resulting set of trajectories as an approximation of the dynamics
defined by the ODEs system. (v) Store the generated set of
trajectories compactly as a dynamic Bayesian network and use
Bayesian inference techniques to perform analysis. A more
detailed description of this construction can be found in the
Methods section while we explain in the Discussion section how
we fixed the number of trajectories to be generated and the
maximum time point upto which the trajectories are to be
constructed.
In the ODE model the PC-initiated and GlcNAc-initiated
complement cascades are merged for convenience. By suppressing
these two cascades to one at a time (by setting the corresponding
expressions in the reaction equations to zero), we constructed two
dynamic Bayesian networks; one for the PC-initiated complement
cascade and the other for GlcNAc-initiated complement cascade.
The range of each variable and parameter was discretized into 6
non-equal size intervals and 5 equal size intervals, respectively.
The time points of interest were set to {0, 100, 200,…,12600}
Regulatory Mechanisms of Complement
PLoS Computational Biology | www.ploscompbiol.org 3 January 2011 | Volume 7 | Issue 1 | e1001059Figure 1. Simplified schematic representation of the complement system and reaction network diagram of the mathematical
model. (A) The complement cascade is triggered when CRP or L-ficolin is recruited to the bacterial surface by binding to ligand PC (classical pathway) or
GlcNAc (lectin pathway). Under inflammation condition,CRP and ficolin interactwitheachother and induceamplification pathways. Theactivated CRP and
L-ficolin on the surface interacts with C1 and MASP-2 respectively and leads to the formation of the C3 convertase (C4bC2a), which cleaves C3 to C3b and
C3a. Deposition of C3b initiates the opsonization, phagocytosis, and lysis. C4BP regulates the activation of complement pathways by: (a) binding to CRP,
(b) accelerating thedecay of the C4bC2a, (c)bindingtoC4b, and (d) preventing the assembly ofC4bC2a (red bars).Solid arrowsanddotted arrowsindicate
proteinconversionsandenzymaticreactions,respectively.(B) Complexes are denoted by thenames of their components, separated by a ‘‘:’’. Single-headed
solid arrows characterize irreversible reactions and double-headed arrows characterize reversible reactions. Dotted arrows represent enzymatic reactions.
The kinetic equations of individual reactions are presented in the supplementary material. The reactions with high global sensitivities are labeledi nr e d .
doi:10.1371/journal.pcbi.1001059.g001
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1:2|106 trajectories generated by sampling the initial values of
the variables and the parameters from the prior, which was
assumed to be uniform distributions over certain intervals. The
quality of the approximations relative to the original ODEs
dynamics was sufficiently high and the details can be found in the
supporting information (Figure S1).
Model calibration and validation
The values of initial concentrations and 14 kinetic parameters
were obtained from literature data (Table S1 and Table S2). To
estimate the remaining 71 kinetic parameters, we generated test
data by incubating human blood under normal and infection-
inflammation conditions with beads coated with PC or GlcNAc
followed by immunodetection of the deposited CRP, C4, C3 and
C4BP in time series. For PC-beads, the concentration levels of
deposited CRP, C4, C3 and C4BP were measured at 8 time points
from 0 to 3.5 h (Figure 2A,B, red dots). For GlcNAc-beads, the
concentration levels of deposited MASP-2, C4, C3 and C4BP were
also measured at 8 time points from 0 to 3.5 h (Figure 2C,D, red
dots).
To estimate unknown kinetic parameters, a two-stage DBN
based method [25] was deployed. In the first stage, probabilistic
inference applied to the discretized DBN approximation was used
to find the combination of intervals of the unknown parameters
that have the maximal likelihood, given the evidence consisting of
the test data. As mentioned above, each unknown parameter’s
value space was divided into 5 equal intervals and the inference
method called factored frontier algorithm [35] was used to infer
the marginal distributions of the species at different time points in
the DBN. We then computed the mean of each marginal
distribution and compared it with the time course experimental
data. To train the model by iteratively improving fitness to data,
we modified the tool libSRES [36] and used its stochastic ranking
evolutionary strategy (SRES), to search in the discretized
parameter space consisting of 5
71 combinations of interval values
of the unknown parameters. The result of this first stage was a
maximum likelihood estimate of a combination of intervals of
parameter values.
In the second stage we then searched within this combination of
intervals having maximal likelihood. Consequently, the size of the
search space for the second stage was just 1/5
71 of the original
search space. We used the SRES search method and the
parameter values thus estimated are shown in Table S2.
In principle, given the noisy and limited experimental data and
the high dimensionality of the system, one could stop with the first
stage [37] and try to work an interval of values for each parameter
rather than a point value. However, in our setting we wanted to
use the ODE model too for conducting in silico experiments such as
varying initial concentrations including the down and over
expression of C4BP. This would have been difficult to achieve
by working solely with our current DBN approximation. We
address this point again in the Discussion section.
Figure 2A–2D shows the comparison of the experimental time
course training data (red dots) with the model simulation profiles
generated using the estimated parameters (blue lines). The model
predictions fit the training data well for most of the cases. In some
cases, the simulations were only able to reproduce the trends of the
data. This may be due to the simplifications assumed by our model
and further refinement is probably necessary.
We next validated the model using previously published
experimental observations [15]. In particular, normalized concen-
tration level of deposited C3 was used to predict the antibacterial
activity since C3 deposition initiated the opsonization process and
the lysis of bacteria. We first simulated the concentration level of
deposited C3 at 1 h under different conditions. We next norma-
lized the results so that the maximum value among them equals to
95% which is the maximum bacterial killing rate reported in the
experimental observations [15]. The normalized values were then
treated as predicted bacterial killing rates. The simulation results
are shown in Figure 2E and 2F as black bars. Consistent with
the experimental data (Figure 2E, grey bars), our simulation
showed that under the infection-inflammation conditions, the P.
aeruginosa, a clinically challenging pathogen, can be efficiently killed
(95% bacterial killing rate) by complement whereas under the
normal condition, only 28% of the bacteria succumbed
(Figure 2E, black bars). Consistent with experimental data,
our simulation results show that in the patient serum, depletion of
CRP or ficolin induced a significant drop in the killing rate from
95% to 33% or 25% respectively, indicating that the synergistic
action of CRP and L-ficolin accounted for around 40% of the
enhanced killing effect. However, in the normal serum, depletion
of CRP or ficolin only resulted in a slight drop in the killing rate
from 28% to 18% or 10% respectively. Furthermore, simulating a
high CRP level (such as in the case of cardiovascular disease)
under the normal healthy condition did not further increase the
bacterial killing rate. As shown in Figure 2F, the simulation
results matched the experimental data. Thus, our model was able
to reproduce the published experimental observations shown in
both Figure 2E and 2F with less than 10% error. This not only
validated our model thus promoting its use for generating
predictions, but also yielded positive evidence in support of the
hypothesized amplification pathways induced by infection-inflam-
mation condition. It also suggested that the antibacterial activity
can be simulated efficiently by the level of deposited C3 and this
was used to generate model predictions described in later sections.
Sensitivity analysis
We performed local and global sensitivity analysis of the model
to identify species and reactions that control complement
activation during infection, and to evaluate the relative importance
of initial concentrations and kinetic parameters for the model
output.
To identify critical species, we first calculated the scaled
absolute local sensitivity coefficients [38] for initial concentrations
of major species using the COPASI tool [39]. The model outputs
were defined as the peak amplitude (maximum activation) and
integrated response (area under the activation curve that reflects
the overall antibacterial activity) of C3 deposition. The results are
shown in Figure 3A. Both the peak amplitude and integrative
response were strongly influenced by initial concentrations of C2
and C3, and were mildly influenced by initial concentrations of
C4BP, C1 and C4. In contrast, the low sensitivities of CRP,
MASP-2 and L-ficolin indicate that over-expression of these
proteins is unlikely to increase the antibacterial activity. Interest-
ingly, it was observed that the integrative response was more
sensitive than the peak amplitude to the changes in the initial
concentration of PC. Since the concentration of PC is correlated to
the amount of invading bacteria, this result implies that the
maximum complement response level may not increase as the
amount of bacteria increases but the overall response (i.e. the area
under the curve obtained by integrating the response level over
time) will be enhanced to combat the increased number of
bacteria.
In order to identify critical reactions, we next computed global
sensitivities for kinetic parameters. To reduce complexity, we used
the DBN approximations. Multi-parametric sensitivity analysis
(MPSA) [40] was performed on the DBN for PC-initiated
Regulatory Mechanisms of Complement
PLoS Computational Biology | www.ploscompbiol.org 5 January 2011 | Volume 7 | Issue 1 | e1001059Figure 2. Model predictions and experimental validation. (A–D) Experimental and simulated dynamics of the complement pathway. The time
profiles of deposited C3, C4, MASP-2, CRP and C4BP under the following four conditions are simulated using estimated parameters and compared
against the experimental data: (A) PC-initiated complement activation under inflammation condition, (B) PC-initiated complement activation under
normal condition. (C) GlcNAc-initiated complement activation under inflammation condition; (D) GlcNAc-initiated complement activation under
normal condition. Blue solid lines depict the simulation results and red dots indicate experimental data. (E–F) Model predictions and experimental
validation of effects of the crosstalk. (E) Simulation results (black bar) of end-point bacterial killing rate in whole serum, CRP depleted serum (CRP-),
ficolin-depleted serum (ficolin-), both CRP- and ficolin-depleted serum (CRP- & ficolin-) under normal and infection-inflammation conditions agree
with the previous experimental observations (gray bar). (F) The simulated bacterial killing effect of high CRP level agrees with the experimental data.
doi:10.1371/journal.pcbi.1001059.g002
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and Methods section). The results are shown in Figure 3B.
Strong controls over the whole system are distributed among the
parameters associated with the immobilisation of C3b with the
surface, interaction between CRP and L-ficolin, cleavage of C2
and C4, and the decay of C3 convertase (see Figure 1B, reactions
labeled in red). The sensitivity of reactions associated with C3, C2
and C4 is consistent with the local sensitivity analysis, which
highlighted the significant role of major complement components.
The high sensitivity of interaction of CRP and L-ficolin confirms
that the overall antibacterial response depends on the strength of
the crosstalk between the classical and lectin pathways. In
addition, since the decay of C3 convertase is one of the regulatory
targets of C4BP, the sensitivity of the system to a change in the rate
of decay of C3 convertase suggested that the regulatory
mechanism by C4BP plays an important role in complement.
Since the critical reactions identified are common in PC- and
GlcNAc-initiated complement cascades, MPSA results using the
other DBN will produce similar results and hence this analysis was
not performed. We next focused our investigation on the
enhancement mechanism by the crosstalk and the regulatory
mechanism by C4BP.
The enhancement mechanism of the antimicrobial
response
Under infection-inflammation conditions where PC-CRP:
L-ficolin or GlcNAc-L-ficolin:CRP complex is formed, the
amplification pathways are triggered. Model simulation showed
that if C1 and L-ficolin or CRP and MASP-2 competed against
each other, the antibacterial activity of the classical pathway or
lectin pathway might be deprived of the amplification pathways
(see Figure S2). Therefore, in order to achieve a stable
enhancement, C1 and L-ficolin (or CRP and MASP-2) must
simultaneously bind to CRP (or L-ficolin). Further, the abilities of
CRP and L-ficolin to trigger subsequent complement cascade were
not affected by the formation of this complex. This is consistent
with the previous experimental observation that two amplification
pathways co-exist with the classical and lectin pathways [15].
According to [15], slight acidosis and mild hypocalcaemia
(pH 6.5, 2 mM calcium) prevailing at the vicinity of the infection-
inflammation triggers a 100-fold stronger interaction between
CRP and L-ficolin compared to the normal condition (pH 7.4,
2.5 mM calcium). This can be explained by the fact that the pH
value and calcium level influence the conformations of CRP and
L-ficolin which in turn govern their binding affinities. Therefore,
the overall antibacterial response which is influenced by the
binding affinity of CRP and L-ficolin will be sensitive to the pH
value and calcium level. To confirm this and further investigate
the effects of pH and calcium on the antibacterial response, we
simulated the complement system under different pH and calcium
conditions. Based on the previous biochemical analysis [15], we
first estimated functions using polynomial regression to predict the
binding affinity of CRP and L-ficolin for different pH values and
calcium levels (Figure 4A,B, right panel). In the right panels of
Figure 4A and 4B, the reported binding affinities [15] were
normalized and are shown as dots. By curve fitting the dots, we
estimated polynomial functions that can be used to predict the
binding affinity. The curves of these functions are shown in red.
We then simulated the C3 deposition dynamics using the
predicted binding affinities at pH ranging from 5.5 to 7.4 in the
presence of 2 mM and 2.5 mM calcium. The simulation time was
chosen to be 3.5 h which is the time frame of the response peaks.
The results are shown in Figure 4A and 4B. Under both 2 mM
and 2.5 mM calcium conditions, decreasing pH induces not only
the increase of the peak amplitude (maximum activation) but also
hastens the peak time (time of maximum activation). To further
compare the effects of the two calcium levels, the dose-response
curves were generated as shown in Figure 4C. The antibacterial
Figure 3. Sensitivity analysis. (A) Local sensitivities were calculated as the control coefficients of the initial protein concentrations for amplitude
and integrated response of C3 deposition. (B) Global sensitivities were calculated according to the MPSA method. The most sensitive parameters are
colored in light blue. kc2 refers to the association rate of C3b with the surface. kd01_1 refers to the association rate of CRP and ficolin. kd07_1 and
kd_07_2 are the Michaelis-Menten constants governing the cleavage rate of C2. kd08_1 and kd_08_2 are the Michaelis-Menten constants governing
the cleavage rate of C4. kt03_1 refers to the decay rate of C4bC2a. Those reactions are colored in red in Figure 1B.
doi:10.1371/journal.pcbi.1001059.g003
Regulatory Mechanisms of Complement
PLoS Computational Biology | www.ploscompbiol.org 7 January 2011 | Volume 7 | Issue 1 | e1001059response was predicted by simulating the system for 1.5 h. At
2 mM calcium (blue curve), the antibacterial response was clearly
greater than at 2.5 mM calcium (pink curve) indicating that slight
hypocalcaemia enhanced the antibacterial activity in a stable
manner. In addition, the pH-responses were reaching saturation
levels when pH was near 5.5 (Figure 4C), implying that the
undesirable complement-enhancement by extreme low pH
condition can be avoided. This also suggests that the saturation
of the pH-response was influenced by the calcium level in the
milieu.
The regulatory mechanism of C4BP on the complement
system
We next investigated the complement regulation by the major
inhibitor, C4BP, under infection-inflammation conditions.
We varied the initial concentration of C4BP and simulated the
PC- and GlcNAc- initiated complement under infection-inflam-
mation conditions. The simulation time was chosen to be 5 h
which is slightly beyond the largest time point of our training
experimental data. The predicted effects of the initial concentra-
tion of C4BP on the antibacterial response in terms of C3
deposition are shown in Figure 5A and 5B. For PC-initiated
complement activation, when the starting amount of C4BP was
perturbed around the normal level of 260 nM [16], increasing
C4BP level only delayed the peak time but did not decrease the
peak amplitude significantly. In contrast, reducing the initial C4BP
level clearly hastened the complement activation and maximized
the activity. Interestingly, the GlcNAc-initiated complement
activation (Figure 5B) behaved differently from the PC-mediated
complement activation (Figure 5A). Around the normal level of
260 nM, perturbing the initial C4BP changed the maximum
activity but did not affect the peak time, suggesting that C4BP
plays distinct roles in regulating the classical and lectin pathways.
To experimentally verify the model predictions, we perturbed
the initial amount of C4BP in the patient sera by (i) spiking with
purified C4BP (high C4BP) and (ii) reducing it by immunopre-
cipitation (low C4BP). The resulting C4BP levels in the normal
and patient sera are shown in Figure S3. The sera were then
incubated with PC- or GlcNAc-beads to initiate complement.
Unaltered serum served as the normal control. The time profiles of
Figure 4. Simulation of antibacterial response with different pH and calcium level. (A) The deposited C3 time profile at pH ranging from
5.5 to 7.4, in the presence of 2 mM calcium. (B) The deposited C3 time profile at pH ranging from 5.5 to 7.4, in the presence of 2.5 mM calcium. In the
right panels of (A) and (B), dots denote the normalized binding affinities of CRP and L-ficolin reported previously [15]. Curves represent the estimated
functions used for predicting. (C) The pH-antibacterial response curves of complement activation in the presence of 2 mM calcium (pink) or 2.5 mM
calcium (blue).
doi:10.1371/journal.pcbi.1001059.g004
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blot (Figure 5C). Comparing the kinetic profiles in the C4BP
deposition initiated by both PC and GlcNAc, we observed the
following order of peak time: high C4BP.normal C4BP.low
C4BP, indicating that the pre-existing initial level of C4BP was
indeed the driving force controlling the deposition of complement
Figure 5. Model prediction and experimental verification of effects of C4BP under infection-inflammation condition. (A–B) Simulation
results. Predicted profiles of the deposited C3 after knocking down or over-expressing C4BP in the presence of PC (A) or GlcNAc (B).
(C–D) Experimental data. Profiles of deposited C4BP (C) or C3 (D) across time points of 0–4 h under infection-inflammation condition via classical
pathway (triggered by PC beads) or lectin pathway (triggered by GlcNAc beads) in untreated or treated sera with increased C4BP or decreased C4BP,
were studied. The deposited protein was resolved in 12% reducing SDS PAGE and detected using polyclonal sheep anti-C4BP. Same amount of pure
protein was loaded to each of the gels as the positive control (labeled as ‘‘C’’ in the image). The black triangles point to the peaks of the time serials
data.
doi:10.1371/journal.pcbi.1001059.g005
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measured the time profiles of deposited C3. Figure 5D shows
that with PC-beads, high C4BP sera induced an early peak and
low C4BP delayed the peak of C3 deposition. The peak amplitude
for all three conditions was at a similar level. These observations
are consistent with the simulation results shown in Figure 5A.
With GlcNAc-beads, reducing C4BP led to a slight increase in the
peak height although the peak coincided with the normal
condition. In contrast, spiking the sera (high C4BP) delayed and
lowered the peak amplitude of C3 deposition. Thus the
experimental results broadly agree with our model predictions
presented in Figure 5B.
We next investigated how C4BP mediates its inhibitory
function. As shown in Figure 1A, the inhibitory effects of C4BP
target different sites in complement: (a) binding to CRP and
blocking C1, (b) preventing the formation of C4bC2a by binding
to C4b, (c) acting as a cofactor for factor I in the proteolytic
inactivation of C4b, and (d) accelerating the natural decay of the
C4bC2a complex, which prevents the formation of C4bC2a and
disrupts already formed convertase. To identify the dominant
mechanism, we employed in silico knockout of the reactions
involved for each mechanism and performed simulations.
Figure 6A–6D shows the model predictions. Among the four
inhibitory mechanisms, only the knockout of reaction (d)
significantly enhanced the complement activation suggesting that
facilitating the natural decay of C4bC2a (C3 convertase) is the
most important inhibitory function of C4BP. This is consistent
with our previous observations derived from sensitivity analysis,
which identified the decay of C3 convertase as a critical reaction.
In addition, as the inhibitory effect of reaction (d) is stronger than
others, knocking out reaction (a) and (b) can even reduce the
complement activity, which is counter-intuitive and emphasizes
the significance of the systems-level understanding.
To confirm our hypothesis that the major inhibitory role of
C4BP relies on accelerating the decay of C3 convertase, we
measured the C4 cleavage at different time points. Figure 6E
(black triangles) indicates the inactive C4b fragments presented
from the time points of 20, 30 and 90 min under high, normal,
and low C4BP conditions, suggesting that C4BP aided cleavage
and inactivation of C4b, and thereby caused the natural decay of
the C4bC2a.
Discussion
Here, we developed an ODE-based dynamic model for the
complement system accompanied by DBN-based approximations
of the ODEs dynamics to understand how the complement activity
is boosted under local inflammation conditions while a tight
surveillance is established to attain homeostasis. Previously
published models of complement system have focused on the
classical and alternative pathways [27,28]. Our model includes the
lectin pathway and more interestingly, the recently identified
amplification pathways induced by local inflammation conditions
[15]. It also encompasses the regulatory effects of C4BP in the
presence of enhanced complement activity.
The ODE model incorporated both the PC-initiated and
GlcNAc-initiated complement together for convenience. By setting
the corresponding expressions to zero one at a time, two DBN
approximations were then derived; one for the PC-initiated
complement cascade and the other for GlcNAc-initiated comple-
ment cascade. For constructing the DBN approximation from an
ODE model, one needs to fix T, the maximal time point upto
which each trajectory is to be explored and N, the number of
trajectories to be generated.
T is set to be suitably beyond the largest time point for which
experimental data is available. In the present study 3.5 h, is the
largest time point of our training experimental data. Based on this
we set T to be 5 h. After constructing the model, we simulated the
system upto 10 h and found no relevant dynamics after 3.5 h.
As for the choice of N, the number of trajectories, ideally one
would like to specify the acceptable amount of error e between the
actual and the approximated dynamics and use e to determine N.
This is however difficult to achieve due to the following:
The dynamic Bayesian network we construct is a factored
Markov chain. It approximates the idealized Markov chain induced
by the ODEs dynamics. This idealized Markov chain is determined
by the discretization of the value spaces of the variables and the
parameters, the discretization of the time domain and the
prior distribution of the initial states. As observed in, Liu
et al [25], given an error bound, a confidence level and the
transition probabilities of the idealized Markov chain, we can
estimate (upper bound) the N required to fall within the given error
bound with the required confidence level. However, our high
dimensional ODE system does not admit closed form solutions and
hence the transition probabilities of the idealized Markov chain will
not be computable. Hence one must make a pragmatic choice of N.
Our approach has been to use a sampling method by which we
can provide a minimum coverage of at least J samples for each
possible combination of interval values of the unknown parameters
inthe equationforeachvariable.Thiswillensurethatthedynamics,
governed by the set of equations (one for each variable) is being
sufficiently sampled at least on a per equation basis. To achieve the
required coverage, one will need N~n:J:KR samples, where R is
the maximal number of unknown parameters appearing in an
equation and n is the number of variables in the system. In our
experience, J~1000 seems to be an adequatechoice. Based on this,
wesampled1:2|106 initialpointsand generatedthecorresponding
trajectories. The quality of the approximations relative to the
original ODEs dynamics was sufficiently high and the details can be
found in the supplementary information (Figure S1).
How to determine N with guaranteed error bounds is however
a basic problem and we are continuing to study this issue.
The study here has involved a tight integration of computational
and experimental aspects. First, we used available biological
information to form the biochemical network and the correspond-
ing ODE system. We then experimentally generated test data to
train the model during the process of parameter estimation. After
constructing the model, one part of the computational exploration
of the model was guided by the previous experimental study
reported in [15]. Specifically, we computed through simulations
the antibacterial response curves for varying combinations of pH
values and calcium concentrations starting with the data provided
in [15]. On the other hand, the second part of the study started
from the computational side, namely, sensitivity analysis. Once
C4BP was confirmed to be an important inhibitor through
sensitivity analysis, we explored its regulatory mechanisms through
simulations and generated the hypotheses concerning the
differentiated influence of C4BP on PC-initiated and GlcNAc-
initiated complement activity as well as the decay of the C3
convertase being the main inhibitory activity of C4BP. These
hypotheses were then experimentally validated.
At present, we have used the DBN approximation to mainly aid the
tasks of parameter estimation and sensitivity analysis. The key idea is to
use the DBN approximation and probabilistic inference to first reduce
the search space and then apply conventional search techniques to this
reduced search space in the second stage. For a n-dimensional search
space with k discretized intervals for each dimension, the first stage can
reduce the search space by a factor of 1=kn.
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silico experiments involving C4BP), we found it more convenient to
use the ODE model. This is due to the fact that the size of the
DBN approximation increases significantly if it must encompass
multiple initial conditions. Alternatively, one must construct a
separate DBN for each choice of initial conditions.
Related probabilistic formalisms such as Multi Terminal Binary
Decision Diagrams (MTBDDs) and Probabilistic Decision Graphs
(PDGs) are also available for analysis. It is not clear at present how
they can be derived directly from the ODE model. One could
however try to convert our DBNs to MTBDDs for purposes of
model checking [41] or develop statistical model checking methods
[42].
As compact representations of the probability distributions,
PDGs are, in spirit, similar to Bayesian networks [43] and can be
computationally as efficient as Bayesian networks [44]. Further,
probabilistic inference can be carried out with a time complexity
linear in the size of the PDGs [44]. Thus, it will be an interesting
Figure 6. Knockout simulations reveal the major role of C4BP. (A) Simulation profiles of C3 deposition with or without reaction a.
(B) Simulation profiles of C3 deposition with or without reaction b. (C) Simulation profiles of C3 deposition with or without reaction c. (D) Simulation
profiles of C3 deposition with or without reaction d. Reactions (a–d) are labeled red in Figure 1A and explained in the caption: (a) C4BP binds to CRP,
(b) C4BP binds to C4b, (c) C4BP prevents the assembly of C4bC2a, and (d) C4BP accelerates the decay of the C4bC2a,. (E) Experimental verification.
Profiles of deposited cleaved/uncleaved C4 fragments across time points of 0–3.5 h under infection-inflammation condition occurring via classical
pathway (triggered by PC beads) in untreated or treated sera with increased C4BP or decreased C4BP were studied. The black triangles point to the
first appearance of inactive fragments.
doi:10.1371/journal.pcbi.1001059.g006
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setting.
Finally, we are aware that model construction is rarely
complete. In the present setting, we included as much of the
relevant and available biological information as possible in our
model. Once the model was calibrated using the test data and was
validated using reported bacterial killing rates, we were reasonably
confident that it could be used as a platform for studying the up-
and down- regulation mechanisms of the complement under local
inflammation conditions. In exploring the model, we were guided
by both the previous experimental study [15] and standard
techniques such as sensitivity analysis. It is clear that the model will
have to be refined and modified as new experimental findings
become available. Indeed, we consider the systematic incremental
updating of a computational model as new data become available,
to be an important task [45].
Turning next to the biological insights gained from this study,
we have shown that increase in PC concentration, representing the
inoculum size of the invading bacteria, affected the overall classical
pathway response time more than the peak amplitude.
Our model analysis confirmed that the enhancement of
complement activity under infection-inflammation condition was
attributable to the synergistic action of CRP and L-ficolin and
supported the existence of the amplification pathways. We showed
that to achieve a steady enhancement, C1 and L-ficolin (or CRP
and MASP-2) should not compete with each other and the
activities of CRP and L-ficolin should remain after forming the
complex CRP:L-ficolin. Our computationally derived antibacte-
rial response curves corresponding to varying pH values and
calcium levels showed that the overall complement response was
sensitive to pH and calcium levels.
Through model analysis we found that with under PC-
activation, perturbation of the initial C4BP level only affected
the peak time but not the amplitude of the response. In contrast, in
the case of GlcNAc-activation, perturbation of the initial level of
C4BP only affected the peak amplitude and not the peak time.
These results imply that C4BP regulates the lectin pathway more
stringently than the classical pathway, which is consistent with
previous experimental findings [46]. Further, for PC-initiated
complement cascade, the over-expression of C4BP only delays but
does not ‘‘turn off’’ the antibacterial response. In contrast,
increased C4BP can efficiently inhibit GlcNAc-initiated comple-
ment activation. This may explain previous observations that
bacteria such as Yersinia enterocolitica, Streptococcus pyogenes, Neisseria
gonorrhoeae, Escherichia coli K1, Moraxella catarrhalis, Candida albicans,
Bordetella pertussis [47,48,49,50,51,52,53] can exploit C4BP to
evade complement.
Through in silico knockouts, we found that, of the four
documented inhibitory roles, C4BP mainly aided the natural
decay of C3 convertase. As the enhancement mechanism by the
crosstalk between CRP and L-ficolin occurs upstream of the
cascade, we envisage C4BP acts downstream to ‘quality control’
and modulate C3 convertase activity. Thus our results suggest that
efficient regulation of complement can be achieved by targeting
the C3 convertase, where the complement pathways merge.
In summary, by integrating our computational model and
experimental observations we have obtained novel insights into
how the complement activation is enhanced during infection and
how excessive complement activity may be avoided. This
introduces a new level of understanding of the host defense
against bacterial infection. It also provides a platform for the
potential development of complement-based immunomodulation
therapies by exploiting the sensitivities of the perturbations of the
pH, calcium and C4BP levels.
Materials and Methods
Computational methods
Mathematical modeling. A system of ODEs was derived
from the reaction network shown in Figure 1. The variables
fx1,x2,:::,xng of the ODE system represent the concentration level
of individual bio-molecular species. The parameters fp1,p2,:::,png
refer to the rate constants of the biochemical reactions. The rate of
each reaction such as catalysis and assembly is described in terms
of mass action or Michaelis-Menten laws. The rate of change of a
species concentration is calculated in the usual way by summing all
reaction rates that produce this species and subtracting all reaction
rates that consume this species. Mathematically, the general
representation of the ODE system will be a collection of equations
of the form:
dxi
dt
~
X ri
j~1
cjnijgj
where ri is the number of reactions associated with species xi and
cj~{1 (cj~z1)i fxi is a reactant (product) of the j th reaction.
Further, the quantities nij denote the stoichiometric coefficients
and gj are rational functions of the form gj~paxa or gj~paxaxb
(mass action law) or gj~paxaxb
 
pbzxa
  
(Michaelis-Menten
law) with a,b [ f1,2,:::,ng and a,b [ f1,2,:::,mg, describing the
reaction rates of the corresponding reactions.
The ODE model was implemented using the open source
software COPASI [39]. It comprises 45 reactions, 42 species and
85 parameters. The values of initial concentrations and 14
parameters were obtained from literature data and the remaining
71 parameters were estimated. The text file of ODE equations is
available in the supplementary information (Text S1).
The Dynamic Bayesian Network approximation. In
order to efficiently perform computationally intensive analysis
tasks, two DBN approximations [25] were constructed: one for the
systems of ODEs modeling PC-initiated complement cascade and
the other for the systems of ODEs modeling GlcNAc-initiated
complement cascade.
Given a system of ODEs with n variables and m parameters as
specified in the previous subsection, we assume that the dynamics
is of interest only for a finite time horizon and that the states of the
system are to be observed only at the discrete time points
ft0,t1,:::,t
^ d dg. Both these assumptions are justified due to the nature
of experimental data and the fact that closed form solutions will
not be available and hence system states can be computed using
numerical integration only for discrete time points.
Next we partition the range of each variable xi into a set of
intervals Ii according to the assumed observation precision. We
also discretize the range of each parameter pj into a set of
intervals, Inzj. The set I~fIig1ƒiƒn|fInzjg1ƒjƒm is called the
discretization. Again, the discretization is justified by the very limited
precision of experimental data. Further, given the fact that
experimental data is often based on cell populations, intervals of
values for the parameters are more meaningful although point
values of the parameters are needed for numerical simulations.
The initial values as well as the parameters of the ODE system are
assumed as distributions (usually uniform) over the intervals
defined by the discretization. In what follows we will loosely speak
of just variables instead of distinguishing between variables and
parameters.
After fixing the discretization and the distribution of initial
states, we sample the initial states of the system (i.e. a vector which
assigns an initial value for each variable and parameter) and
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sampled initial states. The key idea is that a sufficiently large set of
such trajectories is a good approximation of the dynamics defined
by the ODEs system.
The second key idea is that this set of trajectories or rather, the
statistical properties of these trajectories can be compactly stored
in the form of a dynamic Bayesian network by exploiting the
network structure of the pathway and simple counting. As a result,
by querying this DBN representation using standard inferencing
techniques [54] one can analyze, in a probabilistic and
approximate fashion, the dynamics defined by the system of
ODEs. To understand the main features of our construction, we
now briefly review the notion of a DBN. For our purposes, it
suffices to consider a restricted class of the so-called time variant
two slice DBNs. It is a structure of the form (B0,fBd
?g
^ d d
d~1,Pa).I t
has l~nzm nodes at each time slice d. Each node represents a
variable or a parameter of the ODE system at the time point d and
has associated with it a random variable Xd
i , which takes as values
the intervals in Ii. Thus Xd
i [ I stands for the assertion ‘‘at time d,
the value of the variable xi falls in the interval I. In addition, for
each node one also specifies a conditional probability table which
induces a probability distribution for the random variable
associated with the node as explained below.
B0 defines the prior (initial) probability distributions fPr(X0
i )g of the
finite-valued random variables fXig
l
i~1. On the other hand fBd
?g are
two-slice temporal Bayesian networks for the time points ft1,t2,:::,t
^ d dg.
The nodes of Bd
? are fXd{1
i j1ƒiƒlg|fXd
i j1ƒiƒlg and an edge
Xd{1
j ?Xd
i exists in Bd
? iff Xj [ Pa(Xi),w h e r ePa(Xi) denotes the
set of parents Xi. This relation is derived from the structure of the
pathway as defined by the system of ODEs. More precisely, there is an
edge Xd{1
j ?Xd
i iff i~j or 1ƒiƒn (xi is variable) and the variable xj
(in case 1ƒjƒn)o rt h ep a r a m e t e rpj{n (in case nvjƒnzm)a p p e a r s
on the right-hand side of the equation for xi. Thus, in case Xj denotes a
parameter, the only input edge to Xdz1
j will be from Xd
j ,w h i c h
reflects the intuition that the value of a parameter will not change once
i t si n i t i a lv a l u ei sf i x e d .
As mentioned earlier, each node Xd
i will have a condi-
ftional probability table CPTd
i associated with it with entries
of the form Pr(Xd
i [ IijXd{1
i1 [ Ii1,:::,Xd{1
il [ Iil)~r, where
Pa(Xi)~fXi1,:::,Xilg and r [ ½0,1 . Such an entry asserts that r
is the conditional probability of the value of the variable xi falling
in the interval Ii at time point d, given that the value of the
variable xik falls in the interval Iik at time d{1 (for 1ƒkƒl). The
value r is calculated through simple counting, for instance, we
sample N initial states and thus generate N trajectories. We
record, for how many of these trajectories, the value of the variable
xi1 falls in the interval Ii1 and xi2 falls in the interval Ii2 and ...the
value of xil falls in the interval Iil at time d{1. Suppose this
number is K, we count for how many of these K trajectories the
value of the variable xi falls in the interval Ii at time d. If this
number is K0 then the value r is recorded as K0=K.
In summary, the construction process consists of two steps: (i)
derive the underlying graph of the DBN approximation by
exploiting the structure of the ODEs, (ii) fill up the entries of the
conditional probability tables associated with the nodes of the
DBN approximation by sampling the prior distributions, perform-
ing numerical integration for each sample, discretizing generated
trajectories by the predefined intervals and computing the
conditional probabilities by simple counting. Our implementation
of this scheme is available at our website (http://www.comp.nus.
edu.sg/,rpsysbio/pada). It is a Java program that can read
SBML files and generate parallelized code for construction process
to be executed on clusters.
A DBN, being a special kind of Bayesian network, encodes a
large dimensional joint probability distribution. Exploiting the
underlying graphical structure, one can extract the joint marginal
probabilities of specific combinations of variables at various time
points which in turn can be built up from the one-dimensional
marginal probabilities Y(Xd
i [ I). These ‘‘atomic’’ marginal
probabilities can be computed inductively using the structure of
the DBN and the entries in the conditional probability tables
associated with the nodes. Clearly B0 specifies these probabilities
for the initial time point. Assuming that they have been computed
up to the time point d, one computes Y(Xdz1
i [ I) as:
X
Ii1,...Iil
(Pr(Xdz1
i ~IjPr(Xdz1
i [ IijXd
i1 [ Ii1,:::,Xd
il [ Iil) P
Xd
ij [Pa(Xdz!
i )
Y(Xd
ij [Iij)),
where Pa(Xi)~fXi1,:::,Xilg. The Factored Frontier algorithm com-
putes these marginal probabilities approximately but efficiently. It
can also take into account evidence regarding initial conditions
and experimental evidence presented in a suitable form.
We constructed two DBN approximations for PC-initiated
classical complement pathways and GlcNAc-initiated lectin
complement pathways (Table S3 and Table S4). The range of
each variable was discretized into 6 non-equal size intervals and
the range of each parameter was discretized into 5 equal size
intervals. The time points of interest were set to {0, 100, 200,…,
12600} (seconds). 1:2|106 trajectories were generated up to
12600 seconds for each DBN by sampling initial states and
parameters from the prior which is assumed to be uniform
distributions over certain intervals (see Table S5 and Table S6).
The computational workload was distributed on 20 processors in a
cluster and the running time was around 12 h. The quality of the
approximations was evaluated by comparing the concentration
profiles of selected proteins generated by the numerical simulations
and the profiles generated by the DBNs using the FF algorithm.
The details and the comparisons of the profiles can be found in
Figure S1.
Parameter estimation. Unknown parameters were estimat-
ed using a two-stage method. A typical parameter estimation
procedure involves searching in a solution space, in which each
point represents a vector of parameter values. Whether a point is
good or not is measured by an objective function, which captures
the difference between experimental data and prediction
generated by simulations using the corresponding parameters.
Due to the discretized nature of the DBN approximation, the
solution space is transformed into a rectilinear grid tessellated by
hyperrectangles that we call blocks. A block dictates a combination
of intervals of parameter values. Searching in this discrete space
with finite number of blocks is much simpler than in the original
continuous solution space. In the first stage, we adopted the
stochastic ranking evolution strategy (SRES) to search for the
block with minimum objective value. Further, given the fact that
experimental data is often based on cell populations, intervals of
values for the parameters are more meaningful although point
values of the parameters are needed for numerical simulations.
The SRES search was done using a modified version of the tool
libSRES [36] (The modification enables one to perform search in
a discrete solution space). The objective values of blocks were
computed as the weighted sum of squared error between the
experimental data and the expected value of marginal distributions
of the variables. These marginal distributions were inferred from
the DBN using the Factored Frontier algorithm [54] after
supplying the chosen combination of intervals of parameter
values as evidence. The first stage returned a maximum likelihood
estimate of a combination of intervals of parameter values.
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out model analysis for fixed distribution of initial concentrations.
However, we wanted to use the ODE based model too for some
analysis and simulations that required perturbing the initial
concentrations and a finer granularity of parameters. Hence, we
further estimated the real values for unknown parameters in the
second stage where we treated the resulting combination of
intervals of parameter values from the first stage as the (drastically
reduced) search space. In the present setting, the size of this
reduced solution space is 1=571 of the original one. For most
parameter estimation methods, reducing the solution space
increases the chance of randomly picking good starting points
which in turn will lead to faster convergence. Hence the reduction
of solution space we achieved using the DBN approximation
contributes in this way too in improving the performance of the
parameter estimation procedure.
In the second stage, we performed the standard SRES
algorithm using libSRES tool to search for the point with
minimum objective value. A point represents a vector of
parameter values and the objective value of a point was computed
as the weighted sum of squared error between the normalized
experimental data and simulation profile generated using the
chosen parameter values. The obtained parameter values are
available in the supplementary information (Table S2).
Sensitivity analysis. Local sensitivity analysis was performed
using the COPASI tool. Global sensitivity analysis was performed
using a DBN-based implementation of multi-parametric sensitivity
analysis (MPSA) method [40]. The MPSA procedure consists of
the following steps. First, we drew a representative set of samples
from the discretized parameter space. Then for each combination
of intervals of parameter values, we computed the weighted sum of
squared error between experimental data and the expected value
of marginal distributions inferred from the DBN by supplying the
selected combination of intervals of parameter values as evidence.
We next classified the sampled parameter sets into two classes
(good and bad) using a threshold error value and plotted the
cumulative frequency of the parameter values associated with the
two classes. Finally we evaluated the sensitivities as the
Kolmogorov-Smirnov statistic [55] of cumulative frequency
curves.
Experimental methods
Antibodies, proteins & sera. Human C1 complex protein
was purchased from Sigma-Aldrich (St. Louis, MO). Human C4b-
binding protein was from Complement Technology (Tyler,
Texas). Goat anti-rabbit secondary antibody with HRP
conjugation, polyclonal rabbit anti-C3d and anti-C4c antibodies
were purchased from Dako A/S (Glostrup, Denmark). Secondary
anti-sheep antibody was from Upstate (Lake Placid, NY). Rabbit
anti-human C4BP antibody and mouse anti-human C4BP
antibody targeting N-terminal part of C4BP were raised
according to standard protocols. C4BP used as standard for
ELISA was purified from human plasma [56,57]. Serum samples
were obtained from healthy adults and infected patient volunteers
with informed consent. As an infecion marker, the CRP levels in
the serum samples were determined using the CRP Bioassay
ELISA kit (BD Biosciences, San Jose, CA) to confirm the healthy
and infectious status of the samples. All experiments were
performed according to national and institutional guidelines on
ethics and biosafety (Institutional Review Board, Reference Code:
NUS-IRB 08-296).
Manipulation of C4BP level in the serum. The level of
C4BP in the serum was increased by exogenously adding 100 mg
purified C4BP protein per ml serum. The C4BP level in the serum
was reduced by immunoprecipitation. One ml of serum was pre-
cleared using 20 ml Protein G Sepharose (GE healthcare, Uppsala,
Sweden) at 4uC for 1 h with gentle shaking. Sheep polyclonal anti-
C4BP antibody (GeneTex Inc, Irvine, CA) was incubated with the
pre-cleared serum with gentle shaking at 4uC for 1 h. Protein G
Sepharose (20 ml) was then added to the serum containing the
antibody-C4BP complex with gentle shaking at 4uC for 1 h. The
supernatant with reduced C4BP level was stored. For both treated
and untreated serum samples, C4BP level was measured by C4BP
sandwich ELISA to ensure successful addition and depletion of
C4BP (Figure S3). 10% (v/v) healthy serum, which was used in
the subsequent experiments, was prepared by diluting the serum
from healthy adult, in TBS buffer (25 mM Tris, 145 mM NaCl,
pH 7.4, 2.5 mM CaCl2) and 10% (v/v) patient serum was
prepared by diluting in MBS buffer (25 mM MES, 145 mM
NaCl, pH 6.5, 2.0 mM CaCl2).
C4BP quantification by sandwich ELISA. To compare the
C4BP levels between treated and untreated sera, sandwich ELISA
was performed. 10 ml/ml of rabbit anti-human C4BP antibody in
50 ml coating buffer (75 mM sodium carbonate, pH 9.6) was
immobilized on 96-well Maxisorp plates (Nunc, Roskilde,
Denmark) by incubating overnight at 4uC. After four washes
with wash buffer (50 mM Tris-HCL, pH 8.0 supplemented with
2 mM CaCl2, 0.15 M NaCl, 0.1% (v/v) Tween-20), the wells were
blocked with blocking buffer (1% BSA (w/v) in TBS) at 37uC for
1 h. Following four washes, treated and untreated sera were
diluted 2000 times in blocking buffer and 50 ml was added to the
wells and incubated at 37uC for 1 h. After four washes, C4BP
protein amount was detected with mouse anti-C4BP antibody
(1:15000) followed by rabbit anti-mouse HRP-conjugated
secondary antibody (1:2000). ABTS substrate (Roche Diagnos-
tics, Mannheim, Germany) was added and the OD405nm was read.
Wells incubated with blocking buffer instead of serum served as a
negative control.
Complement measurement by pull-down with GlcNAc-
and PC- beads. Untreated serum or sera with increased or
decreased C4BP from both healthy adults and patients were
challenged with GlcNAc-Sepharose (Sigma-Aldrich) to initiate L-
ficolin-mediated complement activation. 20 ml of GlcNAc beads
was added to 500 ml of 10% serum. The beads were collected
between 0.5 h to 4.0 h at intervals of 0.5 h. For patient’s serum,
the beads also underwent incubation at shorter time intervals of 0,
10 and 20 min. For CRP-mediated pathway, PC-Sepharose
(Pierce, Rockford, IL) was used in place of GlcNAc-Sepharose.
Beads were washed thrice with their corresponding incubation
buffer and boiled in SDS-PAGE sample buffer.
Western blot. Protein samples of the different time points
obtained from the previous step was electrophoresed on 12%
SDS-PAGE. The primary antibodies used were polyclonal sheep
anti-C4BP, polyclonal rabbit anti-C4c and polyclonal rabbit anti-
C3d at dilutions of 1:1000. Secondary antibodies used were rabbit
anti-sheep and goat anti-rabbit at dilutions of 1:15,000 and 1:2000
respectively. The fractionated proteins were transferred to PVDF
membranes (Bio-Rad). Membrane blots were incubated in
blocking buffer (3% skimmed milk (w/v) in TBS) overnight at
4uC. Primary antibodies were diluted in TBS supplemented with
3% (w/v) BSA, 0.5% (v/v) Tween-20 and reacted with the blots
with gentle shaking for 2 h at room temperature. After washing
46 for 15 min each with wash buffer (TBS supplemented with
0.5% (v/v) Tween-20), the blots were incubated with HRP
conjugated secondary antibodies with gentle shaking for 2 h at
room temperature. Visualization was performed with the use
of SuperSignal West Pico Chemiluminescent Substrate from
Thermo Scientific (Rockford, IL) and exposed through X-ray.
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Calibrated Densitometer (Bio-Rad). Fixed amount of pure
proteins were used as positive controls and the amounts of
protein on different gels were normalized to the positive control
and compared with each other. Data are representative of three
independent experiments.
Supporting Information
Figure S1 FF inference on DBN vs. ODE-based simulation.
Solid lines represent nominal profiles and dash lines represent
DBN inference results.
Found at: doi:10.1371/journal.pcbi.1001059.s001 (0.09 MB PDF)
Figure S2 Simulation results of the possible outcomes of
alternative models with C1 and L-ficolin or CRP and MASP-2
competition. The cross-talk may (A) does not effect, (B) up-regulate
or (C) down-regulate the complement activation.
Found at: doi:10.1371/journal.pcbi.1001059.s002 (0.20 MB TIF)
Figure S3 C4BP levels measured by C4BP sandwich ELISA for
both treated and untreated serum samples.
Found at: doi:10.1371/journal.pcbi.1001059.s003 (0.10 MB TIF)
Table S1 The initial concentrations.
Found at: doi:10.1371/journal.pcbi.1001059.s004 (0.05 MB PDF)
Table S2 Parameter values. Known parameters are marked
with *.
Found at: doi:10.1371/journal.pcbi.1001059.s005 (0.09 MB PDF)
Table S3 DBN Structure of PC-initiated classical complement
pathway.
Found at: doi:10.1371/journal.pcbi.1001059.s006 (0.08 MB PDF)
Table S4 DBN Structure of GlcNAc-initiated classical comple-
ment pathway.
Found at: doi:10.1371/journal.pcbi.1001059.s007 (0.08 MB PDF)
Table S5 Prior (initial) probability distribution of variables.
Found at: doi:10.1371/journal.pcbi.1001059.s008 (0.09 MB PDF)
Table S6 Prior (initial) probability distribution of parameters.
Found at: doi:10.1371/journal.pcbi.1001059.s009 (0.09 MB PDF)
Text S1 The ODE Model.
Found at: doi:10.1371/journal.pcbi.1001059.s010 (0.08 MB PDF)
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